TCL Archive Study Identifies Women Likely To Benefit From Therapy With Aromatase Inhibitors November 24, 2006
TCL Archive FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate. May 28, 2004
TCL Archive Tracor Lands Second Biggest NCI Contract-$6.6 Million To Manage Commercial Labs’ Portion Of Bioassay Program April 19, 1974
TCL Archive Translation Of “New Biology” Into Clinical Use Identified By DeVita As NCI’s Major Challenge August 16, 1985
